Dermata Therapeutics Inc Warrant
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -2,883 | -3,203 | -2,133 |
EBIT | -2,883 | -6,407 | -4,353 |
Net Income | -2,829 | -3,134 | -2,133 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,125 | -2,704 | -1,147 |
Cash | 4,947 | 4,733 | 7,438 |
Basic Shares | 676 | 444 | 3,930 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | ||||
EBITDA | 247 | -9,674 | -7,842 | -3,172 |
EBIT | -7,794 | -9,674 | -7,856 | -3,172 |
Net Income | -7,794 | -9,610 | -7,948 | -3,433 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,408 | -8,834 | -5,693 | -4,028 |
Cash | 7,438 | 6,241 | 10,798 | 530 |
Basic Shares | 194 | 690 | 520 | 520 |
